Biotech stocks set for a rebound in 2024, analysts say

After a blustery few years, the winds are shifting for biotech stocks. A more favorable interest-rate outlook, an uptick in deals, and innovations in key areas like cancer and immunology are setting …

https://www.marketwatch.com/story/biotech-stocks-set-for-a-rebound-in-2024-analysts-say-24df6236